Terms: = Colorectal cancer AND SFPQ, PSF, 6421, ENSG00000116560, P23246 AND Treatment
7 results:
1. Capecitabine plus oxaliplatin in the treatment of metastatic colorectal cancer at Tygerberg Hospital: a retrospective study.
Kibudde S; Begg W
Pan Afr Med J; 2022; 42():141. PubMed ID: 36160274
[TBL] [Abstract] [Full Text] [Related]
2. Diagnostic performance of
Hotta M; Minamimoto R; Yano H; Gohda Y; Shuno Y
Cancer Imaging; 2018 Jan; 18(1):4. PubMed ID: 29378659
[TBL] [Abstract] [Full Text] [Related]
3. Clinical evaluation of (18)F-fludeoxyglucose positron emission tomography/CT using point spread function reconstruction for nodal staging of colorectal cancer.
Kawashima K; Kato K; Tomabechi M; Matsuo M; Otsuka K; Ishida K; Nakamura R; Ehara S
Br J Radiol; 2016 Jul; 89(1063):20150938. PubMed ID: 27146065
[TBL] [Abstract] [Full Text] [Related]
4. PET optimization for improved assessment and accurate quantification of 90Y-microsphere biodistribution after radioembolization.
Martí-Climent JM; Prieto E; Elosúa C; Rodríguez-Fraile M; Domínguez-Prado I; Vigil C; García-Velloso MJ; Arbizu J; Peñuelas I; Richter JA
Med Phys; 2014 Sep; 41(9):092503. PubMed ID: 25186412
[TBL] [Abstract] [Full Text] [Related]
5. psf knockdown enhances apoptosis via downregulation of LC3B in human colon cancer cells.
Tsukahara T; Matsuda Y; Haniu H
Biomed Res Int; 2013; 2013():204973. PubMed ID: 24288667
[TBL] [Abstract] [Full Text] [Related]
6. Role of miR-19b and its target mRNAs in 5-fluorouracil resistance in colon cancer cells.
Kurokawa K; Tanahashi T; Iima T; Yamamoto Y; Akaike Y; Nishida K; Masuda K; Kuwano Y; Murakami Y; Fukushima M; Rokutan K
J Gastroenterol; 2012 Aug; 47(8):883-95. PubMed ID: 22382630
[TBL] [Abstract] [Full Text] [Related]
7. Progress in metastatic colorectal cancer: growing role of cetuximab to optimize clinical outcome.
García-Foncillas J; Díaz-Rubio E
Clin Transl Oncol; 2010 Aug; 12(8):533-42. PubMed ID: 20709651
[TBL] [Abstract] [Full Text] [Related]
